AI Clinical Decision Support Override Rights
Current understanding
Federal proposals are emerging to establish clinician rights to override AI clinical decision support (CDS) systems in patient care. The Right to Override Act (S2997, introduced) would require healthcare employers to permit such overrides and prohibit retaliation against clinicians who exercise this right, with joint HHS/DOL enforcement. Status: introduced; no companion or hearings noted yet.
Evidence log
- 2026-07-22 — Responsible Artificial Intelligence for Veterans Act of 2026: cross-connection with responsible-ai-for-veterans-act: Both address federal guardrails on AI in health contexts; the Veterans AI bill would apply responsible-AI standards to VA programs, while the CDS override framework governs clinician override rights over AI recommendations more broadly. (novelty: 3)
- 2026-05-19 — Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to “Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model”.: cross-connection with wiser-model-prior-authorization: WISeR’s use of enhanced technology/AI by third-party contractors to make prior-authorization determinations intersects with policy questions about clinician override rights over AI-driven coverage decisions. (novelty: 3)
- 2026-07-16 — A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to “Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model”.: cross-connection with wiser-model-prior-authorization: WISeR relies on AI/enhanced technology for coverage determinations, intersecting with policy debates over rights to override or contest AI-driven clinical decisions. (novelty: 3)